Headquartered in The Sharp Building, Dublin·Fiscal year ends December·NYSE: PRGO·perrigo.com
About Perrigo
Perrigo Company plc (NYSE: PRGO) is a provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions. The company operates across four segments: Self Care (the largest, encompassing U.S. store-brand OTC products and key European brands), Specialty Care (including Skin Health and Women's Health categories with brands such as Opill, ellaOne, and Mederma), Infant Formula (contract and store brand infant formula, currently under strategic review), and All Other (including Oral Care, also under strategic review). Perrigo serves consumers seeking affordable, quality self-care alternatives and competes across multiple OTC categories in the U.S. and Europe. The company is executing a Three-S strategic plan focused on strengthening its core business, streamlining its portfolio through divestitures (including the completed sale of its Dermacosmetics business), and simplifying operations through its Operational Enhancement Program. Updated
Investors love ultra-high-yield dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time.…
Thursday's top analyst upgrades and downgrades included Anheuser-Busch, Fiserv, Foot Locker, Fox, Kohl's, Snowflake, Starbucks, Williams-Sonoma and Zscaler.
Friday's top analyst upgrades, downgrades and initiations included Apple, Canopy Growth, CrowdStrike, Delta Air Lines, Johnson & Johnson, Rio Tinto, Roku, Square, Tilray and Twilio.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Best Buy, Chesapeake Energy, Comcast, Cree, EverQuote, KeyCorp, Lumentum, Nvidia, Vodafone and Xilinx.
Thursday was a down day for the broad U.S. markets. After coming off a very positive Wednesday, the markets gave some of their gains back in this session. Crude oil continued lower…
Thursday was a mixed day for the broad U.S. markets. Crude oil took another small step back in the session. The S&P 500 sectors were more or less split down the middle.
The top analyst upgrades, downgrades and other research calls from Wednesday include Alkermes, Cigna, International Paper, Medtronic, Tesla and Western Digital.
The top analyst upgrades, downgrades and other research calls from Tuesday include Alcoa, Alphabet, BP, Epizyme, FirstEnergy, First Solar, KeyCorp, Nvidia and Vale.
The top analyst upgrades, downgrades and other research calls from Thursday include AMD, Caterpillar, Chipotle, eBay, Facebook, Microsoft, Sirius XM and Starbucks.
The top analyst upgrades, downgrades and other research calls from Friday include Boston Scientific, Ciena, GoDaddy, Kratos Defense, Lipocine, Repligen, Teladoc and Vodafone.
The top analyst upgrades, downgrades and other research calls from Friday include AMD, CVS Health, Disney, Fiat Chrysler, Kinross Gold, Kohl's and NVIDIA.